Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii
寄生虫自噬是艾滋病相关病原体弓形虫的关键生存机制
基本信息
- 批准号:10296195
- 负责人:
- 金额:$ 45.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAffinityAmino AcidsAutophagocytosisAutophagosomeBiogenesisBiological ModelsCellsCellular biologyChronicComplexCystDevelopmentDiseaseEatingEukaryotaEventEvolutionGenesGoalsHealthHeart DiseasesHomeostasisImmuneIn VitroIndividualInfectionLiteratureLung diseasesMeasuresMediatingMembraneMitochondriaMitoticMolecularMolecular GeneticsMusOcular ToxoplasmosisOrgan TransplantationParasitesPathway interactionsPatientsPlayPropertyPublishingRNA InterferenceReactive Oxygen SpeciesRecurrenceRiskRoleSamplingSeedsStructureTestingTissuesToxoplasmaToxoplasma gondiiToxoplasmosisTransplant RecipientsVisionWorkbasechronic infectiondefined contributionexperiencein vivoinnovationinsightmutantnanobodiesnervous system disordernovelpathogenpreventrecruitspatiotemporaltoxoplasmic encephalitisvirtual
项目摘要
Reactivation of chronic Toxoplasma gondii infection causes ocular, cardiac, respiratory, and neurologic disease in immune-deficient individuals. Current treatments fail to eliminate the slow replicating, persistent Toxoplasma bradyzoite cysts that seed reactivation and disease, which manifests most severely as Toxoplasmic encephalitis. Our long-term goal is to identify critical liabilities for disrupting Toxoplasma persistence, thereby eliminating the risk of potentially fatal Toxoplasmic encephalitis in at-risk individuals. Toward this goal, we have recently demonstrated that the viability of bradyzoite cysts in culture and in infected mice critically relies on the parasite having a functional autophagy pathway based on targeted disruption of TgATG9. TgATG9 deficient bradyzoites show markedly reduced autophagy and severe loss of viability in culture and in experimentally infected mice. Since autophagy is necessary for cellular homeostasis, our findings support a new concept of disrupting parasite homeostasis to quell infection. However, little is known about autophagy in Toxoplasma and pursuing this concept requires identifying new and divergent components in the pathway. To meet this need, we will discover novel early components of the autophagy pathway, define how they cooperatively mediate the development of autophagic structures, and determine their contributions to parasite persistence in vitro and in vivo. Completing the proposed studies will provide proof-of-concept that targeting parasite homeostasis is an effective strategy to disrupt persistence.
慢性弓形虫感染的重新激活会导致免疫缺陷个体出现眼部、心脏、呼吸系统和神经系统疾病。目前的治疗方法无法消除复制缓慢、持续存在的弓形虫缓殖子包囊,这些包囊会导致重新激活和疾病,最严重的表现为弓形虫脑炎。我们的长期目标是确定破坏弓形虫持久性的关键责任,从而消除高危人群患潜在致命弓形虫脑炎的风险。为了实现这一目标,我们最近证明了缓殖子包囊在培养物和受感染小鼠中的生存能力严重依赖于具有基于 TgATG9 靶向破坏的功能性自噬途径的寄生虫。 TgATG9 缺陷的缓殖子在培养物和实验感染的小鼠中表现出明显减少的自噬和严重的活力丧失。由于自噬对于细胞稳态是必要的,因此我们的研究结果支持了破坏寄生虫稳态以平息感染的新概念。然而,人们对弓形虫中的自噬知之甚少,追求这一概念需要识别该途径中新的和不同的成分。为了满足这一需求,我们将发现自噬途径的新型早期成分,定义它们如何协同介导自噬结构的发育,并确定它们对体外和体内寄生虫持久性的贡献。完成拟议的研究将提供概念验证,即针对寄生虫体内平衡是破坏持久性的有效策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vernon Bruce Carruthers其他文献
Vernon Bruce Carruthers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vernon Bruce Carruthers', 18)}}的其他基金
Identifying novel players in Toxoplasma autophagy during chronic infection”
识别慢性感染期间弓形虫自噬的新参与者 –
- 批准号:
10223735 - 财政年份:2021
- 资助金额:
$ 45.65万 - 项目类别:
Identifying novel players in Toxoplasma autophagy during chronic infection”
识别慢性感染期间弓形虫自噬的新参与者 –
- 批准号:
10372165 - 财政年份:2021
- 资助金额:
$ 45.65万 - 项目类别:
Rational design of CNS-permeable cathepsin L inhibitors for treatment of chronic toxoplasmosis
中枢神经系统渗透性组织蛋白酶 L 抑制剂治疗慢性弓形虫病的合理设计
- 批准号:
9813831 - 财政年份:2016
- 资助金额:
$ 45.65万 - 项目类别:
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii
寄生虫自噬是艾滋病相关病原体弓形虫的关键生存机制
- 批准号:
10669199 - 财政年份:2015
- 资助金额:
$ 45.65万 - 项目类别:
T. GONDII CHLOROQUINE RESISTANCE TRANSPORTER AND REDOX
弓形虫氯喹抗性转运蛋白和氧化还原
- 批准号:
8938727 - 财政年份:2015
- 资助金额:
$ 45.65万 - 项目类别:
Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii
寄生虫自噬是艾滋病相关病原体弓形虫的关键生存机制
- 批准号:
10461953 - 财政年份:2015
- 资助金额:
$ 45.65万 - 项目类别:
Proteolytic modulation of toxoplasma invasion proteins
弓形虫入侵蛋白的蛋白水解调节
- 批准号:
8384858 - 财政年份:2008
- 资助金额:
$ 45.65万 - 项目类别:
Proteolytic modulation of toxoplasma invasion proteins
弓形虫入侵蛋白的蛋白水解调节
- 批准号:
7579559 - 财政年份:2008
- 资助金额:
$ 45.65万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 45.65万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 45.65万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 45.65万 - 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 45.65万 - 项目类别: